GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R
These GLP-1 effects include properties such as an anorexic peptide, beneficial cardiovascular actions in humans, increased pulmonary surfactant formation in human and experimental animals, pancreatic islet neogenesis and proliferative and antiapoptotic actions
Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery
Were here to support you every step of the way, ensuring you have the knowledge and tools you need to succeed
The principles of Good Laboratory Practices were designed to rebuild confidence in science, and they remain just as critical today
This is a superior advantage of GLP-1R pharmaceuticals as many other drugs used to treat T2DM are weight neutral or actual cause weight gain